Recurrent Grade 1 Follicular Lymphoma
specificThe reemergence of grade 2 follicular lymphoma after a period of remission.
46
Centers
20
Active Trials
—
Cancer Funding
Top Centers for Recurrent Grade 1 Follicular Lymphoma(46)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 72.6 |
| 2 | Princess Margaret Cancer CentreToronto, ON High-Volume Research Center | 72.6 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 63.8 |
| 4 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 63.8 |
| 5 | NCI Comprehensive Active Research Program | 63.8 |
| 6 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 63.8 |
| 7 | NCI Comprehensive Active Research Program | 63.8 |
| 8 | NCI Comprehensive Active Research Program | 63.8 |
| 9 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 63.8 |
| 10 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 63.8 |
| 11 | NCI Comprehensive Active Research Program | 63.8 |
| 12 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 63.8 |
| 13 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 63.8 |
| 14 | University of Illinois Cancer CenterChicago, IL Active Research Program | 63.8 |
| 15 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 63.8 |
| 16 | Cancer Center at IllinoisUrbana, IL Active Research Program | 63.8 |
| 17 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 63.8 |
| 18 | BC CancerVancouver, BC Active Research Program | 63.8 |
| 19 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 42.3 |
| 20 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 42.3 |
| 21 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 42.3 |
| 22 | NCI Comprehensive | 42.3 |
| 23 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 42.3 |
| 24 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 42.3 |
| 25 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 42.3 |
| 26 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 42.3 |
| 27 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 42.3 |
| 28 | NCI Comprehensive | 42.3 |
| 29 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 42.3 |
| 30 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 42.3 |
| 31 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 42.3 |
| 32 | NCI Comprehensive | 42.3 |
| 33 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 42.3 |
| 34 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 42.3 |
| 35 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 42.3 |
| 36 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 42.3 |
| 37 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 42.3 |
| 38 | Cleveland Clinic Cancer CenterCleveland, OH | 42.3 |
| 39 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 42.3 |
| 40 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive | 42.3 |
| 41 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 42.3 |
| 42 | Boston University Cancer CenterBoston, MA | 42.3 |
| 43 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 42.3 |
| 44 | Penn State Cancer InstituteHershey, PA | 42.3 |
| 45 | University of Cincinnati Cancer CenterCincinnati, OH | 42.3 |
| 46 | 42.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →